Bellerophon Therapeutics, Inc.
USD0.01
-0.01 (-36.84%)
CEO
Craig R. Jalbert CIRA
IPO Date
2015-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.01
Prev. Close
$0.02
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$0.10
Market Cap
$0.00B
Volume
0.00M
| 14,607 |
| $0.83 |
| 9 Jun 2023 | Shah Parag Suresh | VP of Business Operations | A-Award | Disposed | 50,000 | $0.83 |
| 9 Jun 2023 | Bruder Scott P | director | A-Award | Disposed | 14,607 | $0.83 |
| 9 Jun 2023 | Cloyd Mary Ann | director | A-Award | Disposed | 14,607 | $0.83 |
| 9 Jun 2023 | Teufel Crispin | director | A-Award | Disposed | 14,607 | $0.83 |
| 9 Jun 2023 | Fernandes Peter | See Remarks | A-Award | Disposed | 100,000 | $0.83 |
| 9 Jun 2023 | Dekker Martin | See Remarks | A-Award | Disposed | 50,000 | $0.83 |
| 7 Jun 2023 | Puissance Life Science Opportunities Fund VI | 10 percent owner | S-Sale | Disposed | 134,421 | $0.83 |
| 19 May 2023 | Puissance Life Science Opportunities Fund VI | 10 percent owner | S-Sale | Disposed | 560,000 | $9.46 |